Showing results (1901-1910 of 1,960) with videos related to

Sort By:
Pageof 196
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2018
Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical TrialsMatthew J Maurer, Hervé Ghesquières, Brian K Link, et al.
Nature Communications|August 8, 2024
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulationMatthew E Stokes, Kerstin Wenzl, C Chris Huang, et al.
Oncotarget|April 21, 2017
Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to deliveryAlan H Bryce, Jan B Egan, Mitesh J Borad, et al.
Blood Cancer Journal|June 20, 2024
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCLKerstin Wenzl, Matthew E Stokes, Joseph P Novak, et al.
Blood Advances|September 20, 2023
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent eraSanjal H Desai, Michael A Spinner, Andrew M Evens, et al.
American Journal of Hematology|April 28, 2021
Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemiaJithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
Blood|August 11, 2018
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangementsRebecca A Luchtel, Surendra Dasari, Naoki Oishi, et al.
BJA Open|July 1, 2024
Cardiopulmonary exercise variables and their association with postoperative morbidity and mortality after major oesophagogastric cancer surgery-a multicentre observational studyMalcolm A West, Saqib Rahman, Sandy Jack, et al.
Annals of Neurology|April 12, 2022
Heterozygous PNPT1 Variants Cause Spinocerebellar Ataxia Type 25Mathieu Barbier, Melanie Bahlo, Alessandra Pennisi, et al.
Circulation|May 4, 2013
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillationLars Wallentin, Renato D Lopes, Michael Hanna, et al.
Pageof 196